Gemcitabine resistance in triple-negative breast cancer cells can be reverted by Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol

The development of drug resistance to chemotherapeutic agents has consistently presented a challenge in terms of the treatment of patients with triple-negative breast cancer (TNBC). In the present study, gemcitabine (dFdC)-resistant TNBC cells were established, and the effects of lentivirus-deoxyrib...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yan, Jiang, Haiyang, Gu, Ming, Zu, Cong, Zheng, Xinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509507/
https://www.ncbi.nlm.nih.gov/pubmed/32973960
http://dx.doi.org/10.3892/ol.2020.12109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509507/
https://www.ncbi.nlm.nih.gov/pubmed/32973960
http://dx.doi.org/10.3892/ol.2020.12109

Ejemplares similares